Stay updated on Safe Doses CX-2029 in Solid Tumors and DLBCL Clinical Trial

Sign up to get notified when there's something new on the Safe Doses CX-2029 in Solid Tumors and DLBCL Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Safe Doses CX-2029 in Solid Tumors and DLBCL Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    Footer revision updated from v3.3.3 to v3.3.4; this is a maintenance update that does not alter study details or user-facing functionality. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-01-15T04:32:09.000Z thumbnail image
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    No Change Detected
  4. Check
    25 days ago
    Change Detected
    Summary
    The Study Locations section was updated with added site listings across multiple U.S. states and international districts (Jongno-gu, Seodaemun-gu, Manchester Greater), and several previously listed locations were removed. This follows revision v3.3.3.
    Difference
    2%
    Check dated 2025-12-24T12:15:35.000Z thumbnail image
  5. Check
    54 days ago
    Change Detected
    Summary
    Revision label updated from v3.2.0 to v3.3.2; no study content or functionality changes. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2025-11-25T13:51:44.000Z thumbnail image
  6. Check
    62 days ago
    Change Detected
    Summary
    Removed the government funding notice about NIH operating status; core study details remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2025-11-18T07:24:14.000Z thumbnail image
  7. Check
    83 days ago
    Change Detected
    Summary
    The two screenshots show the same study page with only minor layout adjustments and an updated last-updated timestamp; there are no changes to eligibility criteria, primary or secondary outcomes, enrollment, or study status. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-10-27T20:54:36.000Z thumbnail image
  8. Check
    105 days ago
    Change Detected
    Summary
    Added a government-status notice, confirmed NIH Clinical Center is open, added new condition 'Malignant lymphoma, large B-cell, diffuse' and revision v3.2.0; removed 'Carcinoma of esophagus' and revision v3.1.0.
    Difference
    5%
    Check dated 2025-10-06T07:51:17.000Z thumbnail image

Stay in the know with updates to Safe Doses CX-2029 in Solid Tumors and DLBCL Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Safe Doses CX-2029 in Solid Tumors and DLBCL Clinical Trial page.